(Q43779676)

English

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease

scientific article published in October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

26 November 2017

0 references

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

pulmonary emphysema

1 reference

based on heuristic

inferred from title

Niki L Reynaert

object named as

Niki Reynaert

11

0 references

object named as

William MacNee

21

0 references

Leonardo M. Fabbri

object named as

Leonardo M Fabbri

15

0 references

Ruth Tal-Singer

12

object named as

Ruth Tal-Singer

1 reference

Europe PubMed Central

26 November 2017

Emiel F M Wouters

13

object named as

Emiel F M Wouters

1 reference

Europe PubMed Central

26 November 2017

author name string

Donavan T Cheng

1

1 reference

Europe PubMed Central

26 November 2017

Deog Kyeom Kim

2

1 reference

Europe PubMed Central

26 November 2017

Debra A Cockayne

3

1 reference

Europe PubMed Central

26 November 2017

Anton Belousov

4

1 reference

Europe PubMed Central

26 November 2017

Hans Bitter

5

1 reference

Europe PubMed Central

26 November 2017

Michael H Cho

6

1 reference

Europe PubMed Central

26 November 2017

Annelyse Duvoix

7

1 reference

Europe PubMed Central

26 November 2017

Lisa D Edwards

8

1 reference

Europe PubMed Central

26 November 2017

David A Lomas

9

1 reference

Europe PubMed Central

26 November 2017

Bruce E Miller

10

1 reference

Europe PubMed Central

26 November 2017

Alvar Agustí

14

1 reference

Europe PubMed Central

26 November 2017

Alex Rames

16

1 reference

Europe PubMed Central

26 November 2017

Sudha Visvanathan

17

1 reference

Europe PubMed Central

26 November 2017

Stephen I Rennard

18

1 reference

Europe PubMed Central

26 November 2017

Paul Jones

19

1 reference

Europe PubMed Central

26 November 2017

Harsukh Parmar

20

1 reference

Europe PubMed Central

26 November 2017

Gerhard Wolff

22

1 reference

Europe PubMed Central

26 November 2017

Edwin K Silverman

23

1 reference

Europe PubMed Central

26 November 2017

Ruth J Mayer

24

1 reference

Europe PubMed Central

26 November 2017

Sreekumar G Pillai

25

1 reference

Europe PubMed Central

26 November 2017

TESRA and ECLIPSE Investigators

26

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

1 October 2013

1 reference

Europe PubMed Central

26 November 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

26 November 2017

188

1 reference

Europe PubMed Central

26 November 2017

8

1 reference

Europe PubMed Central

26 November 2017

948-957

1 reference

Europe PubMed Central

26 November 2017

Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Association of radiographic emphysema and airflow obstruction with lung cancer

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

The receptor for advanced glycation end products (RAGE) and the lung

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

RAGE: a multi-ligand receptor unveiling novel insights in health and disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Human S100A12: a novel key player in inflammation?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Genome-wide association study identifies five loci associated with lung function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Optimization and standardization of lung densitometry in the assessment of pulmonary emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

LocusZoom: regional visualization of genome-wide association scan results

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Association of the RAGE G82S polymorphism with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Does RAGE protect smokers from COPD?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Receptor for advanced glycation end products contributes to postnatal pulmonary development and adult lung maintenance program in mice.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Decreased plasma sRAGE levels in COPD: influence of oxygen therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201302-0247OC

21 January 2018

Identifiers

10.1164/RCCM.201302-0247OC

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43779676&oldid=2103260623"